In addition, a more recent study investigating genetic and biochemical markers in patients with AD associated several intronic variants in FPN1, TF and TFR genes, concluding that iron accumulation and oxidative damage might contribute to AD pathophysiology [43]. This evidence concerns the gene TFRC and Alzheimer disease.